Abstract
Diabetic and normal rats were fed rodent feed and drank passion fruit (Passiflora edulis) that was sweetened with sucrose, or saccharin plus cyclamate. During the 21 days of feeding, the blood glucose and body weight increased to dangerous levels only in the diabetic rats that drank passion fruit sweetened with sucrose.
Keywords: Passion fruit, diabetes, saccharin, cyclamate, blood glucose, carotenoids, LDL, diabetics, sweetened, hypolycema
The Natural Products Journal
Title:Influence of Passion Fruit (Passiflora edulis, f. flavicarpa, DEG) Juice Sweetened with Sucrose, Saccharin and Cyclamate on Blood Glucose in Normal and Diabetic Rats (Rattus norvegicus)
Volume: 2 Issue: 2
Author(s): Kelly C. S. Nascimento and Armando U. O. Sabaa-Srur
Affiliation:
Keywords: Passion fruit, diabetes, saccharin, cyclamate, blood glucose, carotenoids, LDL, diabetics, sweetened, hypolycema
Abstract: Diabetic and normal rats were fed rodent feed and drank passion fruit (Passiflora edulis) that was sweetened with sucrose, or saccharin plus cyclamate. During the 21 days of feeding, the blood glucose and body weight increased to dangerous levels only in the diabetic rats that drank passion fruit sweetened with sucrose.
Export Options
About this article
Cite this article as:
C. S. Nascimento Kelly and U. O. Sabaa-Srur Armando, Influence of Passion Fruit (Passiflora edulis, f. flavicarpa, DEG) Juice Sweetened with Sucrose, Saccharin and Cyclamate on Blood Glucose in Normal and Diabetic Rats (Rattus norvegicus), The Natural Products Journal 2012; 2 (2) . https://dx.doi.org/10.2174/2210315511202020108
DOI https://dx.doi.org/10.2174/2210315511202020108 |
Print ISSN 2210-3155 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-3163 |
Call for Papers in Thematic Issues
Ayurvedic medicinal therapeutic approaches for inflammatory and neurodegenerative disorders
Usually, in our elderly population, neurodegenerative disorders occur due to neuron death. Alzheimer?s disease (AD) is an irreversible and progressive neurodegenerative disease. Dementia is the leading cause of AD, which affects about 30 million people worldwide. According to the World Alzheimer report 2018, a new case of dementia develops every ...read more
Recent Advances in Biotransformation of Bioactive Terpenoids using Aspergillus niger
Biotransformation is the reaction catalyzed by biological catalysts of either isolated enzymes or whole cell cultures of microorganisms. This process has been extensively applied in the conversion of bioactive terpenoids with high regio- and stereospecifity. This process has been also applied in the lead discovery and development. Aspergillus niger has ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Choline Nutrition Programs Brain Development Via DNA and Histone Methylation
Central Nervous System Agents in Medicinal Chemistry The Evolution of Schizophrenia: A Model for Selection by Infection, with a Focus on NAD
Current Pharmaceutical Design Pharmacological Treatments for Fragile X Syndrome Based on Synaptic Dysfunction
Current Pharmaceutical Design Mitogenomics: Recognizing the Significance of Mitochondrial Genomic Variation for Personalized Medicine
Current Pharmacogenomics and Personalized Medicine Neurocognitive Functioning and Cannabis Use in Schizophrenia
Current Pharmaceutical Design Patent Selections
Recent Patents on CNS Drug Discovery (Discontinued) Histone Acetylation as a Potential Therapeutic Target in Motor Neuron Degenerative Diseases
Current Pharmaceutical Design Types of Voltage-Gated Calcium Channels: Molecular and Electrophysiological Views
Current Hypertension Reviews Carvacrol as a Potential Neuroprotective Agent for Neurological Diseases: A Systematic Review Article
CNS & Neurological Disorders - Drug Targets CAR, The Continuously Advancing Receptor, in Drug Metabolism and Disease
Current Drug Metabolism An Update on Peptide Drugs for Voltage-Gated Calcium Channels
Recent Patents on CNS Drug Discovery (Discontinued) Role of Microfluidics in Blood-Brain Barrier Permeability Cell Culture Modeling: Relevance to CNS Disorders
CNS & Neurological Disorders - Drug Targets Serum Thiol-Disulphide Levels in Epileptic Pediatric Patients
Combinatorial Chemistry & High Throughput Screening Use of Non-steroidal Anti-inflammatory Drugs in Pregnancy: Impact on the Fetus and Newborn
Current Drug Metabolism Synthesis and Anticonvulsant Activity of α-Amino Acid Amide Derivatives
Current Bioactive Compounds Therapeutic Application of Histone Deacetylase Inhibitors for Stroke
Central Nervous System Agents in Medicinal Chemistry NAP (Davunetide) Provides Functional and Structural Neuroprotection
Current Pharmaceutical Design Abnormal Functional and Structural Asymmetry as Biomarker for Schizophrenia
Current Topics in Medicinal Chemistry Strategic Aspects of NPY-Based Monoclonal Antibodies for Diagnosis and Treatment of Breast Cancer
Current Protein & Peptide Science Opioid Receptor Ligands Derived from Food Proteins
Current Pharmaceutical Design